Event:
-
Making All Data Count: FDA Acceptance of non-US Clinical
Trials
- Hosted By:
-
ComplianceOnline
- Start:
- Tuesday - Nov 19, 2013 10:00 AM
- End Time:
- Tuesday - Nov 19, 2013 11:30 AM
- Location:
- Online
- This webinar on FDA acceptance of non-US clinical trials will discuss the current FDA requirements for using clinical data from non-IND/IDE clinical trials in support of an IND and/or marketing approval application.
Why Should You Attend:
FDA acceptance criteria for non-IND/IDE clinical trials are based on internationally recognized standards of quality, ethics, and practices for human subject protection. An adequately designed non-US study can be used to greatly reduce the time of cost of getting the tested product to the US market.
If you have conducted non-IND clinical trials at non-US locations or if you would like to understand how non-IND trials can be used successfully to support an IND/IDE or a marketing approval application, this seminar is a must for you. The speaker will share his extensive experience in multi-national IND and non-IND studies to underscore the critical issues that need to be addressed when using non-US data for discussions with FDA. Case studies from drugs, biologics, diagnostic kits and medical devices will be used to highlight product specific issues with non-US clinical trials.
Areas Covered:
-Comparison of US and non-US regulatory requirements for clinical trials
-Types of clinical trials with regards to product development and marketing approval
-Parameters of quality of clinical trials: investigators and sites
-Acceptable design of non-US clinical trials
Acceptable ethical and human subject protection practices
-Acceptable data collection, analysis, monitoring, and documentation practices
-Role of IRBs, ethics committees and other regulatory bodies in clinical trial quality control
-FDA’s opinion of non-US regulatory review and approval of clinical trials
-FDA’s international clinical trial initiatives
-FDA audits of non-US clinical sites
-Best practices for using non-US human experience with products marketed outside US
-Waiver and other options for non-IND clinical trial data
Who Will Benefit:
This webinar will provide valuable assistance to all personnel in:
-Compliance/Regulatory affairs professionals
-Clinical trial professionals
-Sponsors and investigator-sponsors of clinical trials that use non-US sites
-Project Managers for clinical trials
-Senior management for companies interested in non-US trials
-People investing in FDA-regulated product development projects
- Website:
-
Visit the website for detail info